Niagen Bioscience licenses potential Parkinson’s therapy

Niagen Bioscience licenses potential Parkinson’s therapy

Publication date: Jul 09, 2025

Niagen Bioscience (NAGE) announced it has entered into a worldwide exclusive commercial license agreement with Haukeland University Hospital in Bergen, Norway.

Concepts Keywords
Bioscience Agreement
Investor Announced
Norway Bioscience
Parkinsons Clinical
Smarter Exclusive
Licenses
Nage
Niagen
Parkinson
Parkinsons
Potential
Therapy
Tipranks
Trial

Original Article

(Visited 14 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *